Western blotting market-by product (consumables and equipment), by application (disease diagnosis, agriculture, and biochemical research), and by region-analysis, share, trends, sizes, and forecasts 2014-2025

SDKI Inc. published a new report on the Western Blotting Market-Analysis, Shares, Trends, Sizes, and Forecasts 2014-2025. This study includes the statistical and analytical approaches needed to grow the Western blotting market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-53419

The Western blotting market reached US $ 650.8 million in 2017 and is expected to grow at a CAGR of 7.8% during the forecast period.

Overall market growth can be attributed to increased research and R & D spending by pharmaceutical and biotechnology companies, the prevalence of HIV / AIDS, and the growth of the proteomics market. According to statistics released by the Joint United Nations Program on HIV / AIDS, 6.9 million people worldwide suffered from HIV in 2017. Also, according to another UNAIDS statistic, 1.8 million [1.4 million-2.4 million] were newly infected with HIV in 2017. Western blotting has proven to be more accurate than ELISA (enzyme-linked immunosorbent assay) and is useful for detecting AIDS. Not only AIDS, but other immune-related diseases such as Lyme disease can be detected more accurately using this technology. Therefore, the increasing incidence of these diseases has led to a surge in demand for this technology, which will drive market growth.

Market Segments

The Western blotting market is divided by product, application and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

By Product
Based on the product, the market is divided into consumables and equipment. The consumables segment contains kits, reagents, and more. The consumables segment dominates the market in terms of revenue generation. This can be due to an increased detection of illnesses and an increased incidence of these illnesses.

Applications
Based on applications, the market is divided into biomedical research, disease diagnosis, agriculture and more. In terms of revenue generation, the biomedical research segment

dominated the global western breading market. Government funding for this research has improved significantly, supporting the growth of this segment. As this method is used to detect various diseases such as Lyme disease and HIV, the growth of the biomedical research segment is expected to grow significantly over the next few years.

Regional Overview
The Western blotting market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, and other Asia Pacific). ) And other regions.

Detailed contents of the survey report
https://www.sdki.jp/reports/western-blotting-market/53419

Of these regions, the North American region is expected to occupy a significant market share during the forecast period. This may be due to increased use of GM crops in the United States and increased R & D spending in the field of molecular biology. Meanwhile, the Asia-Pacific region has also witnessed growing demand for this technology. This increasing demand is expected to be due to the strong growth of the biotechnology industry in Japan and China.

Major key players on the market
Key players in the Western blotting market include Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, Bio-Techne Corporation, F. Hoffmann-

La Roche Ltd., GE Healthcare, PerkinElmer, Inc., Advansta, Inc., Cell. Signaling Technology and so on. The survey includes a detailed competitive analysis of these major companies in the Western blotting market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.